Healthtech Startups

Wellthy operates a care concierge service with a dedicated team of coordinators and advisers who help families navigate healthcare systems, access care providers, and manage care-related tasks across aging, disability, mental health, and other life stages. The company combines human care expertise with a proprietary database of 400,000+ vetted providers and AI-powered tools to support member experience.

9 investors

WTHN provides acupuncture, herbal medicine, and acupressure products based on Traditional Chinese Medicine to address stress, pain, and other health concerns. The company operates physical studios and distributes products through retail partners.

9 investors

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment. Its approach aims to achieve durable efficacy for cancer patients while avoiding the severe systemic side effects of conventional immuno-oncology agents.

9 investors

9 investors

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor. Its products are aimed at patients with multiple autoimmune conditions with unmet medical needs.

9 investors

10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

8 investors

1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies. The platform targets undruggable targets and aims to improve R&D productivity in the biopharma industry.

8 investors

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases. The company uses its Therapeutic Vector Evolution platform to design customized vectors for targeted treatment delivery.

8 investors

Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support. It serves members across the U.S. including those covered by Medicaid, and works with providers, courts, employers, and health systems.

8 investors

Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors. The company serves oncology patients and healthcare providers in the cancer care sector.

8 investors

Alchemy 43 offers aesthetic and self-care treatments, providing appointment-based cosmetic services to consumers.

8 investors

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.

8 investors

Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases. The device gathers daily health data and transmits it in real time to parents and healthcare providers.

8 investors

Ångström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.

8 investors

Anise Health offers culturally-responsive online therapy and health coaching designed for the Asian American community, matching adults with licensed therapists and certified coaches trained in cultural sensitivity. The telehealth service accepts insurance and is available in seven US states including California, New York, and Texas.

8 investors

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease. Its pipeline includes a candidate for Type 1 Myotonic Dystrophy (DM1), a form of muscular dystrophy.

8 investors

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers. The company focuses on advancing DDR-based therapies through strategic partnerships.

8 investors

Asha Health provides AI-powered software that automates clinical workflows and administrative tasks for medical practices. The platform enables healthcare providers to operate more efficiently with artificial intelligence automation.

8 investors

Assured Allies provides insurance and health engagement solutions for older adults, partnering with financial institutions to deliver preventive care and protection services. The company serves financial institutions and their policyholders aged 60+.

8 investors

Augmedix builds AI-driven documentation technology for clinicians, aiming to reduce time spent on technology so providers can focus on patient care. It serves healthcare organizations and their clinical staff.

8 investors

Axle Health provides a logistics and scheduling platform for home health care providers that optimizes clinician routing, staffing decisions, and patient coordination through real-time data and predictive forecasting.

8 investors

Axuall provides a workforce intelligence solution for healthcare staffing and operations, using clinician data to address needs in credentialing and workforce management. It serves healthcare organizations and leaders across the US.

8 investors

Béa provides at-home fertility treatments that bridge the gap between natural conception attempts and in-vitro fertilization, offering clinic-level care with personalized support. The company serves couples and individuals seeking early-stage fertility care accessible outside traditional clinical settings.

8 investors

Because Market is a direct-to-consumer company that sells incontinence products, including bladder leak protection underwear, wipes, and supplements, with discreet home delivery and subscription options. The company also offers skincare and wellness products designed for people managing incontinence.

8 investors